Cancer Patients Recover By Taking Repurposed Anti-Parasitic Drugs

Joe Tippens, a 67-year-old businessman, was diagnosed with small cell lung cancer in 2016 and was given a terminal prognosis. He discovered a potential remedy through a veterinarian's story about a scientist who cured her lab mice and herself of cancer using fenbendazole, an antiparasitic drug. Tippens started taking fenbendazole, along with Theracurmin and CBD, and was cancer-free three months later. Dr. William Makis, an oncologist, has studied Tippens' approach and treats cancer patients worldwide, with several patients declared cancer-free after doing the protocol. Fenbendazole works by boosting protein p53, blocking glucose uptake, disrupting microtubules, and affecting mitochondrial function, ultimately starving cancer cells. Researchers have reported several case reports of fenbendazole curing Stage 4 cancer cases, and a review concluded that fenbendazole affects energy metabolism, leading to significant advances in cancer treatment. Donna Leland, a show host, was diagnosed with Stage 3 cervical and endometrial cancer and declined chemotherapy and radiation, instead taking fenbendazole and ivermectin, and is now cancer-free. The Tippens Protocol has gained international recognition, with an estimated 70,000 followers, and Tippens has refused to monetize his discovery. Despite the FDA not approving fenbendazole for human use, many doctors are recommending it for cancer treatment, and researchers are exploring other FDA-approved drugs that might be repurposed for cancer treatment.